Bliss GVS Pharma Limited has informed the Exchange regarding allotment of 66380 securities pursuant to ESOP/ESPS at its meeting held on December 09, 2025
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bliss GVS Pharma has allotted 66,380 securities to employees under its Employee Stock Option Plan (ESOP) or Employee Stock Purchase Scheme (ESPS). The allotment was approved at a board meeting held on December 9, 2025. This increases the company's total outstanding share count by 66,380 shares. No new capital is being raised from the public or from the market.
Minor dilution for existing shareholders due to the issuance of new shares, but the impact is small given the size of the allotment. This is a routine employee incentive action and is generally neutral to mildly positive as it aligns employee interests with company performance.